President Donald J. Trump announced on June 1 that the United States will withdraw from the 2015 multinational Paris climate agreement to reduce global warming and the greenhouse effect. This withdrawal will “greatly undermine” the global effort to curb the damaging impact of climate change on human health, according to a press release issued by ACP.
Author: Healio ophthalmology
VIDEO: Selective laser trabeculoplasty studied in patients with uveitic glaucoma
KIAWAH, S.C. — Kenzo J. Koike, MD, a senior resident at the Medical University of South Carolina, discusses his presentation at the Kiawah Eye meeting on use of selective laser trabeculoplasty for treatment of uveitic glaucoma. Koike and colleagues found that, even though there are relative contraindications for use of SLT for this indication, there were no visually significant complications and IOP reductions were maintained at 1 year in the small patient cohort.
Trying to understand and close the rural health care gap
Many of the health care challenges facing the United States, including lack of utilization of preventive care, socioeconomic factors that affect access to and ability to afford health care, and the shortage of primary care clinicians, are affecting res…
OCTANe’s Ophthalmology Technology Summit to unite physicians and industry on innovation
Healio.com/OSN: What is the goal of the OCTANe OTS meeting?
Tracking cataract surgery outcomes leads to improved performance
MILAN – Tracking the outcomes of cataract surgery helps individual surgeons and clinics improve their performance, leading to overall better results and greater patient satisfaction, according to a speaker. “Patient expectations are sky-high nowadays,” Richard S. Davidson, MD, said at the OSN Italy meeting. “We are under a lot of pressure to do more surgery in less time, with decreased reimbursement and a high demand for better outcomes.”
Crystalens may affect patients’ perception of colors
The Crystalens accommodating implant from Bausch + Lomb is designed to provide patients with improved refractive and visual outcomes at distance and intermediate. Most patients experience a change in color perception after cataract surgery because the …
VIDEO: Careful management needed for best outcomes after cataract surgery in diabetic patients
MILAN, Italy – At the OSN Italy meeting, Keith A. Warren, MD, gives pearls on how to manage patients with diabetic retinopathy and other retinovascular disease at the time of cataract surgery.
Patient education increases use of advanced lens technology
MILAN — Patient education can increase the demand for advanced technology lens implants, according to one surgeon. “Patients, when educated, more often than not choose a lens which will allow them to see better, to correct astigmatism or to have the full range of vision,” Jeffrey D. Horn, MD, said at the OSN Italy meeting.
AMA: Practice ownership no longer the majority among physicians
The proportion of patient care physicians who have an ownership stake in their medical practice dropped below 50%, marking the first time that physician practice owners fell under the majority since practice arrangement trends have been documented, according to a new study by the AMA.“Patients benefit when physicians practice in settings they find professionally and personally rewarding, and the AMA strongly supports a physician’s right to practice in the setting of their choice,” Andrew W. Gurman, MD, president of AMA, said in a press release. “The AMA is committed to (Read more...)
Nicox receives FDA approval of Zerviate for ocular itching
The FDA has approved the new drug application for Zerviate to treat ocular itching associated with allergic conjunctivitis, according to a Nicox press release.Zerviate is the first topical ocular formulation of the antihistamine cetirizine.
Nicox receives FDA approval of Zerviate for ocular itching
The FDA has approved the new drug application for Zerviate to treat ocular itching associated with allergic conjunctivitis, according to a Nicox press release.Zerviate is the first topical ocular formulation of the antihistamine cetirizine.
Nicox receives FDA approval of Zerviate for ocular itching
The FDA has approved the new drug application for Zerviate to treat ocular itching associated with allergic conjunctivitis, according to a Nicox press release.Zerviate is the first topical ocular formulation of the antihistamine cetirizine.
Alimera Sciences reports $6.7 million quarterly net loss
A first-quarter net loss of $6.7 million was reported by Alimera Sciences, compared with an $11.1 million net loss for the first quarter of 2016. Operating expenses went down from $14.2 million in 2016’s first quarter to $11.5 million in 2017’s first quarter, according to a press release. Research, development and medical affairs expenses went down approximately 30% to $2.1 million.
VIDEO: Experienced surgeon shares views on mix and match with latest lens technologies
MILAN — Is there a role for mix and match now that multifocal lens technology has improved and the choice of lenses is wider? At the OSN Italy meeting, Magda Rau, MD, shares her views on this topic and her outcomes of a study.
Noninvasive laser therapy may be alternative to MIGS
MILAN — Transscleral micropulse laser therapy may be an effective alternative to minimally invasive glaucoma surgery in the treatment of mild to moderate glaucoma, according to a surgeon here.“It is a safe, minimally invasive and effective procedure that you can do in your office under topical anesthesia. I believe it has a great future as a treatment,” Rolando Toyos, MD, said at the OSN Italy meeting.
TearClear announces $4.5 million in funding for drop filter technology
TearClear has completed $4.5 million in Series A financing to advance development of its filter technology, designed to deliver preservative-free drops from preserved multi-dose products, the company announced in a press release.Visionary Venture Fund …
Second Sight reports $7.5 million first-quarter loss
Second Sight Medical Products reported a net loss of $7.5 million, or $0.16 per share, in the first quarter of 2017 compared with a net loss of $5.8 million, or $0.16 per share, in the same quarter of last year, the company announced in a press release…
Regression time shorter with ophthalmic artery chemosurgery plus intravitreous chemotherapy
Ophthalmic artery chemosurgery with intravitreous chemotherapy to treat class 3 retinoblastoma vitreous seeds resulted in a shorter time to regression compared with ophthalmic artery chemosurgery alone, according to a retrospective study.Researchers at…
In Memoriam of our founder: Charles B. Slack
THOROFARE, NJ — Charles B. Slack, founder of Charles B. Slack Incorporated, which later became SLACK Incorporated and the Wyanoke Group, publisher of many health care titles including Healio.com, died on May 27 at the age of 87 years.Slack was the founder of a company that became one of the last great American family-owned medical publishers to succeed in the 20th and 21st centuries.
Top five stories from ASCRS 2017
The American Society of Cataract and Refractive Surgery annual meeting took place May 5 to 9 in Los Angeles. Healio.com/OSN was there to cover breaking news and developments in cataract and refractive surgery.